This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Mar 17:342:d1354.

doi: 10.1136/bmj.d1354.

What have we learnt from the rosiglitazone saga?

Victor M Montori, Nilay D Shah

PMID: 21415102
DOI: 10.1136/bmj.d1354

Editorial

What have we learnt from the rosiglitazone saga?

Victor M Montori et al. BMJ. 2011.

. 2011 Mar 17:342:d1354.

doi: 10.1136/bmj.d1354.

Authors

Victor M Montori, Nilay D Shah

PMID: 21415102
DOI: 10.1136/bmj.d1354

No abstract available

PubMed Disclaimer

Comment in

Rosiglitazone saga. Should we throw the baby out with the bathwater?
McDonald C. McDonald C. BMJ. 2011 Apr 21;342:d2566. doi: 10.1136/bmj.d2566. BMJ. 2011. PMID: 21511790 No abstract available.

Comment on

Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.
Loke YK, Kwok CS, Singh S. Loke YK, et al. BMJ. 2011 Mar 17;342:d1309. doi: 10.1136/bmj.d1309. BMJ. 2011. PMID: 21415101 Free PMC article. Review.

Similar articles

Rosiglitazone saga. Demonisation of rosiglitazone.
Heazlewood VJ. Heazlewood VJ. BMJ. 2011 Apr 21;342:d2571; author reply d2573. doi: 10.1136/bmj.d2571. BMJ. 2011. PMID: 21511791 No abstract available.
Rosiglitazone saga. Should we throw the baby out with the bathwater?
McDonald C. McDonald C. BMJ. 2011 Apr 21;342:d2566. doi: 10.1136/bmj.d2566. BMJ. 2011. PMID: 21511790 No abstract available.
Rosiglitazone and cardiovascular disease revisited.
Davis TM, Prins JB. Davis TM, et al. Med J Aust. 2010 Aug 2;193(3):134-5. doi: 10.5694/j.1326-5377.2010.tb03829.x. Med J Aust. 2010. PMID: 20678037 No abstract available.
Cardiovascular risk of rosiglitazone: another perspective.
Waksman JC. Waksman JC. J Pharm Pharmacol. 2008 Dec;60(12):1573-82. doi: 10.1211/jpp.60.12.0002. J Pharm Pharmacol. 2008. PMID: 19000361 Review.
Cardiovascular effects of thiazolidinediones: a review of the literature.
Acharya D, Falik R. Acharya D, et al. South Med J. 2009 Jan;102(1):51-6. doi: 10.1097/SMJ.0b013e318189879f. South Med J. 2009. PMID: 19077768 Review.

See all similar articles

Cited by

Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.
Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc. 2012 Oct;60(10):E1-E25. doi: 10.1111/j.1532-5415.2012.04188.x. Epub 2012 Sep 19. J Am Geriatr Soc. 2012. PMID: 22994865 Free PMC article. No abstract available.
State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning.
Ross JS, Jackevicius C, Krumholz HM, Ridgeway J, Montori VM, Alexander GC, Zerzan J, Fan J, Shah ND. Ross JS, et al. Health Aff (Millwood). 2012 Jan;31(1):188-98. doi: 10.1377/hlthaff.2011.1068. Health Aff (Millwood). 2012. PMID: 22232110 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information